D-erythro-1-(imidazol-4-yl)glycerol 3-phosphate

Metabolite details

Identifier

HFYBTHCYPKEDQQ-RITPCOANSA-N

InChI Key

HFYBTHCYPKEDQQ-RITPCOANSA-N

IUPAC name

(2R,3S)-2,3-dihydroxy-3-(1H-imidazol-4-yl)propyl dihydrogen phosphate

Preferred name

D-erythro-1-(imidazol-4-yl)glycerol 3-phosphate

INN name

—

Synonym

D-erythro-1-(Imidazol-4-yl)glycerol 3-phosphate

ChEBI

CHEBI:17805

Reactome pathways

• No Reactome pathways listed for this metabolite.

Observed in studies

• Bioaccumulation of therapeutic drugs by human gut bacteria: cross-feeding metabolite analysis (FIA-MS) (E.rectale;S.salivarius assays)
• Metabolite profile of mice hippocampus following Toxoplasma gondii infection
• Changes and correlations of intestinal flora and liver metabolite profiles in mice with gallstones
• Brain metabolomic profiling of eastern honey bee (Apis cerana) infested with the mite Varroa destructor.
• Metabolic profilings of rat INS-1 β-cells under changing levels of essential amino acids

Observed in differential profiles

• G4_Eubacterium_rectale_DMSO_30_vs_G3_Eubacterium_rectale_Duloxetine_47
• G5_Phosphate_Buffered_Saline_7_days_vs_G2_Toxoplasma_gondii_PRU_7_days
• Control_vs_Lithogenic_Diet
• Mite_Infestation_vs_Control
• Mite_Infestation_vs_Control
• G1_Control_vs_G2_Arginine_Addition